Qualigen Therapeutics, Inc. (QLGN) shares are surging more than 47 percent on Tuesday morning trade, continuing an upsurge since November 18. There were no corporate announcements on the day to impact the stock movement.
On November 15, the company has reported a 47 percent increase in third-quarter revenue to $1.2 million from 40.8 million a year ago, on higher unit volume of product sale.
Currently, shares are at $1.84, up 47 percent from the previous close of $1.25 on a volume of 25,116,559. For the 52-week period, the share have traded in a range of $0.93-$4.66 on average volume of 1,024,928.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.